University of Rochester Medical Center
Gynecologic Oncology fellowship · Rochester, NY · Program website
Obstetrics and Gynecology residency here · Other fellowships: Maternal-Fetal Medicine · Reproductive Endocrinology and Infertility
Roster not collected yet. There's no list of this program's own faculty, trainees, or papers yet. Below is University of Rochester Medicine's research in gynecologic oncology, which the program shares with other departments and affiliated hospitals.
Gynecologic Oncology at University of Rochester Medicineshared by every program there, not this program's own
Institution-level: all gynecologic oncology publications from University of Rochester Medicine and affiliated institutions, since 2022. Updated 2026-11-07; refreshed daily.
Works per year · * 2026 so far
Gynecologic Oncology research topics at University of Rochester Medicine
Papers in the window; each links to the list on OpenAlex.
Most cited at University of Rochester Medicine since 2024
All gynecologic oncology papers there on OpenAlex
- The global, regional, and national burden of cancer, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023Lisa M Force et al. · The Lancet · 2025 · PubMed · cited 515
- Pembrolizumab plus chemotherapy in advanced or recurrent endometrial cancer: overall survival and exploratory analyses of the NRG GY018 phase 3 randomized trialRamez Nassef Eskander et al. · Nature Medicine · 2025 · PubMed · cited 97
- Symptom monitoring with electronic patient-reported outcomes during cancer treatment: final results of the PRO-TECT cluster-randomized trialEthan Basch et al. · Nature Medicine · 2025 · PubMed · cited 99
- Survival among patients treated with total mesorectal excision or selective watch-and-wait after total neoadjuvant therapy: a pooled analysis of the CAO/ARO/AIO-12 and OPRA randomized phase II trialsH. Williams et al. · Annals of Oncology · 2025 · PubMed · cited 54
- First-Line Lenvatinib Plus Pembrolizumab Versus Chemotherapy for Advanced Endometrial Cancer: A Randomized, Open-Label, Phase III TrialChristian Marth et al. · Journal of Clinical Oncology · 2024 · PubMed · cited 77
- Niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer: final overall survival results from the PRIMA/ENGOT-OV26/GOG-3012 trialBradley J. Monk et al. · Annals of Oncology · 2024 · PubMed · cited 203
- Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T ConsortiumMichael David Jain et al. · Journal of Clinical Oncology · 2024 · PubMed · cited 92
- Management of Fatigue in Adult Survivors of Cancer: ASCO–Society for Integrative Oncology Guideline UpdateJulienne E. Bower et al. · Journal of Clinical Oncology · 2024 · PubMed · cited 328
- Organ Preservation and Survival by Clinical Response Grade in Patients With Rectal Cancer Treated With Total Neoadjuvant TherapyHannah M. Thompson et al. · JAMA Network Open · 2024 · PubMed · cited 151
- Lymphatic endothelial-like cells promote glioblastoma stem cell growth through cytokine-driven cholesterol metabolismLinjie Zhao et al. · Nature Cancer · 2024 · PubMed · cited 55
Add to your program's websitea badge, your paper list, a feed
For program directors and coordinators. Both update with the site and need no account.
<a href="https://openprograms.org/programs/university-rochester-medical-center-gyn-onc"><img src="https://openprograms.org/programs/university-rochester-medical-center-gyn-onc/badge.svg" alt="University of Rochester Medical Center Gynecologic Oncology fellowship on OpenPrograms" height="20"></a>Something wrong or missing on this page? Use the correction form below; changes show up in both.